Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems

Bibliography

• Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;51(12):3353-61
   PubMed Web of Science ®Google Scholar
• Group DP. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23(8):857-66
   PubMed Web of Science ®Google Scholar
• Patterson CC, Gyurus E, Rosenbauer J, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012;55(8):2142-7
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 2004;164(17):1917-24
   PubMed Web of Science ®Google Scholar
• Group DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329(14):977-86
   PubMed Web of Science ®Google Scholar
• Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57(12):3169-76
   PubMed Web of Science ®Google Scholar
• Davis EA, Keating B, Byrne GC, et al. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997;20(1):22-5
   PubMed Web of Science ®Google Scholar
• Kaufman FR, Epport K, Engilman R, et al. Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications 1999;13(1):31-8
   PubMed Web of Science ®Google Scholar
• Barnard K, Thomas S, Royle P, et al. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr 2010;10:50
   PubMed Web of Science ®Google Scholar
• Johnson SR, Cooper MN, Davis EA, et al. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents. Diabet Med 2013;30(9):1126-31
   PubMed Web of Science ®Google Scholar
• Barnea-Goraly N, Raman M, Mazaika P, et al. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care 2014;37(2):332-40
   PubMed Web of Science ®Google Scholar
• Gaudieri PA, Chen R, Greer TF, et al. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care 2008;31(9):1892-7
   PubMed Web of Science ®Google Scholar
• Group DCCT. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes Control and Complications Trial. J Pediatr 1994;125(2):177-88
   PubMed Web of Science ®Google Scholar
• Acerini CL, Williams RM, Dunger DB. Metabolic impact of puberty on the course of type 1 diabetes. Diabetes Metab 2001;27(4 Pt 2):S19-25
   PubMedGoogle Scholar
• Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011;7(7):385-95
   PubMed Web of Science ®Google Scholar
• Tamborlane WV, Sherwin RS, Genel M, et al. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300(11):573-8
   PubMed Web of Science ®Google Scholar
• Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366(17):1616-24
   PubMed Web of Science ®Google Scholar
• Maahs DM, Horton LA, Chase HP. The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther 2010;12(Suppl 1):S59-65
   PubMedGoogle Scholar
• Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114(6):1601-5
   PubMed Web of Science ®Google Scholar
• Misso ML, Egberts KJ, Page M, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010(1):Cd005103
   PubMedGoogle Scholar
• Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25(7):765-74
   PubMed Web of Science ®Google Scholar
• Bangstad HJ, Danne T, Deeb L, et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl 12):82-99
   PubMedGoogle Scholar
• Muller-Godeffroy E, Treichel S, Wagner VM. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study. Diabet Med 2009;26(5):493-501
   PubMed Web of Science ®Google Scholar
• Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27(7):1554-8
   PubMed Web of Science ®Google Scholar
• Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003;112(3 Pt 1):559-64
   PubMed Web of Science ®Google Scholar
• Cummins E, Royle P, Snaith A, et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010;14(11):iii-v; xi-xvi, 1-181
   PubMed Web of Science ®Google Scholar
• Pańkowska E, Błazik M, Dziechciarz P, et al. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10(1):52-8
   PubMed Web of Science ®Google Scholar
• Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012;157(5):336-47
   PubMed Web of Science ®Google Scholar
• Kordonouri O, Hartmann R, Lauterborn R, et al. Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in pediatric patients: one-year follow-up comparison by matched-pair analysis. Diabetes Care 2006;29(1):133-4
   PubMed Web of Science ®Google Scholar
• Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia 2013;56(11):2392-400
   PubMed Web of Science ®Google Scholar
• Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev 2009;25(2):99-111
   PubMed Web of Science ®Google Scholar
• Heinemann L, Krinelke L. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol 2012;6(4):954-64
   PubMedGoogle Scholar
• Heinemann L. Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements? J Diabetes Sci Technol 2009;3(6):1490-500
   PubMedGoogle Scholar
• Jones SM, Quarry JL, Caldwell-McMillan M, et al. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol Ther 2005;7(2):233-40
   PubMedGoogle Scholar
• O'Connell MA, Gilbertson HR, Donath SM, et al. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type. Diabetes Care 2008;31(8):1491-5
   PubMed Web of Science ®Google Scholar
• Ahola AJ, Makimattila S, Saraheimo M, et al. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes 2010;2(3):194-202
   PubMedGoogle Scholar
• Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care 2013;36(11):3613-19
   PubMed Web of Science ®Google Scholar
• Rabbone I, Scaramuzza AE, Ignaccolo MG, et al. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study. Diabetes Res Clin Pract 2014, doi:10.1016/j.diabres.2013.12.026
   PubMed Web of Science ®Google Scholar
• Shashaj B, Busetto E, Sulli N. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). Diabet Med 2008;25(9):1036-42
   PubMed Web of Science ®Google Scholar
• Enander R, Gundevall C, Stromgren A, et al. Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. Pediatr Diabetes 2012;13(7):545-51
   PubMed Web of Science ®Google Scholar
• Ramotowska A, Szypowska A. Bolus calculator and wirelessly communicated blood glucose meter effectively reduce hypoglycemia in type 1 diabetic children - randomized controlled trial. Diabetes Metab Res Rev 2014;30(2):146-53
   PubMed Web of Science ®Google Scholar
• Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev 2008;108(7):2482-505
   PubMed Web of Science ®Google Scholar
• Oliver NS, Toumazou C, Cass AE, et al. Glucose sensors: a review of current and emerging technology. Diabet Med 2009;26(3):197-210
   PubMed Web of Science ®Google Scholar
• Damiano ER, El-Khatib FH, Zheng H, et al. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care 2013;36(2):251-9
   PubMed Web of Science ®Google Scholar
• Christiansen M, Bailey T, Watkins E, et al. A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013;15(10):881-8
   PubMed Web of Science ®Google Scholar
• Keenan DB, Mastrototaro JJ, Zisser H, et al. Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms. Diabetes Technol Ther 2012;14(3):225-31
   PubMed Web of Science ®Google Scholar
• Weinzimer SA, Beck RW, Chase HP, et al. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther 2005;7(5):675-80; discussion 81-3
   PubMedGoogle Scholar
• Mauras N, Fox L, Englert K, et al. Continuous glucose monitoring in type 1 diabetes. Endocrine 2013;43(1):41-50
   PubMed Web of Science ®Google Scholar
• Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805
   PubMed Web of Science ®Google Scholar
• Langendam M, Luijf YM, Hooft L, et al. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012(1):Cd008101
   PubMedGoogle Scholar
• Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359(14):1464-76
   PubMed Web of Science ®Google Scholar
• Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34(4):795-800
   PubMed Web of Science ®Google Scholar
• Mauras N, Beck R, Xing D, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2012;35(2):204-10
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Abelseth J, Bode BW, et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10(5):377-83
   PubMed Web of Science ®Google Scholar
• Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care 2009;32(12):2245-50
   PubMed Web of Science ®Google Scholar
• Slover RH, Welsh JB, Criego A, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 2012;13(1):6-11
   PubMed Web of Science ®Google Scholar
• Kordonouri O, Pankowska E, Rami B, et al. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010;53(12):2487-95
   PubMed Web of Science ®Google Scholar
• Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012;55(12):3155-62
   PubMed Web of Science ®Google Scholar
• Kordonouri O, Hartmann R, Pankowska E, et al. Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study. Pediatr Diabetes 2012;13(7):515-18
   PubMed Web of Science ®Google Scholar
• Buckingham B, Beck RW, Ruedy KJ, et al. Effectiveness of early intensive therapy on beta-cell preservation in type 1 diabetes. Diabetes Care 2013;36(12):4030-5
   PubMed Web of Science ®Google Scholar
• Matyka KA. Sweet dreams?--nocturnal hypoglycemia in children with type 1 diabetes. Pediatr Diabetes 2002;3(2):74-81
   PubMedGoogle Scholar
• Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34(9):2023-5
   PubMed Web of Science ®Google Scholar
• Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13(11):1129-34
   PubMed Web of Science ®Google Scholar
• Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14(3):205-9
   PubMed Web of Science ®Google Scholar
• Ly TT, Nicholas JA, Retterath A, et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310(12):1240-7
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369(3):224-32
   PubMed Web of Science ®Google Scholar
• Ly TT, Nicholas JA, Retterath A, et al. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care 2012;35(7):1462-5
   PubMed Web of Science ®Google Scholar
• Guerci B, Meyer L, Salle A, et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab 1999;84(8):2673-8
   PubMed Web of Science ®Google Scholar
• Buckingham B, Chase HP, Dassau E, et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33(5):1013-17
   PubMed Web of Science ®Google Scholar
• Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013;15(8):622-7
   PubMed Web of Science ®Google Scholar
• Danne T, Tsioli C, Kordonouri O, et al. The PILGRIM study: In silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther 2014. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Elleri D, Allen JM, Nodale M, et al. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes. Diabet Med 2010;27(4):480-4
   PubMed Web of Science ®Google Scholar
• Kadish AH. Automation control of blood sugar. I. A servomechanism for glucose monitoring and control. Am J Med Electron 1964;3:82-6
   PubMedGoogle Scholar
• Renard E, Costalat G, Chevassus H, et al. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 2006;32(5 Pt 2):497-502
   PubMed Web of Science ®Google Scholar
• Steil GM, Rebrin K, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55(12):3344-50
   PubMed Web of Science ®Google Scholar
• Weinzimer SA, Steil GM, Swan KL, et al. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31(5):934-9
   PubMed Web of Science ®Google Scholar
• Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375(9716):743-51
   PubMed Web of Science ®Google Scholar
• Atlas E, Nimri R, Miller S, et al. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33(5):1072-6
   PubMed Web of Science ®Google Scholar
• El-Khatib FH, Russell SJ, Nathan DM, et al. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2(27):27ra27
   PubMed Web of Science ®Google Scholar
• Group DCCT. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991;90(4):450-9
   PubMed Web of Science ®Google Scholar
• Marzelli MJ, Mazaika PK, Barnea-Goraly N, et al. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 2014;63(1):343-53
   PubMed Web of Science ®Google Scholar
• Elleri D, Acerini CL, Allen JM, et al. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther 2010;12(1):35-9
   PubMed Web of Science ®Google Scholar
• Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes 2011;60(11):2672-82
   PubMed Web of Science ®Google Scholar
• O'Grady MJ, Retterath AJ, Keenan DB, et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35(11):2182-7
   PubMed Web of Science ®Google Scholar
• Sherr JL, Cengiz E, Palerm CC, et al. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013;36(10):2909-14
   PubMed Web of Science ®Google Scholar
• Nimri R, Danne T, Kordonouri O, et al. The ‘Glucositter’ overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes 2013;14(3):159-67
   PubMed Web of Science ®Google Scholar
• Elleri D, Allen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36(4):838-44
   PubMed Web of Science ®Google Scholar
• Buckingham BA, Beck RW, Ruedy KJ, et al. The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis. Diabetes Technol Ther 2013;15(5):401-8
   PubMed Web of Science ®Google Scholar
• Dauber A, Corcia L, Safer J, et al. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care 2013;36(2):222-7
   PubMed Web of Science ®Google Scholar
• Renard E, Cobelli C, Kovatchev BP. Closed loop developments to improve glucose control at home. Diabetes Res Clin Pract 2013;102(2):79-85
   PubMed Web of Science ®Google Scholar
• Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368(9):824-33
   PubMed Web of Science ®Google Scholar
• Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36(7):1851-8
   PubMed Web of Science ®Google Scholar
• Nimri R, Muller I, Atlas E, et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014;15(2):91-9
   PubMed Web of Science ®Google Scholar
• Hovorka R, Elleri D, Thabit H, et al. Overnight closed loop insulin delivery in young people with type 1 diabetes: a free-living randomised clinical trial. Diabetes Care 2014, doi 10.2337/DC13-644
   Web of Science ®Google Scholar
• Bakhtiani PA, Zhao LM, El Youssef J, et al. A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy. Diabetes Obes Metab 2013;15(12):1065-70
   PubMed Web of Science ®Google Scholar
• Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol 2012;8(7):425-33
   PubMed Web of Science ®Google Scholar
• Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002;19(9):746-51
   PubMed Web of Science ®Google Scholar
• Hoey H, Aanstoot HJ, Chiarelli F, et al. Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care 2001;24(11):1923-8
   PubMed Web of Science ®Google Scholar
• Hofer SE, Heidtmann B, Raile K, et al. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria. Pediatr Diabetes 2010;11(2):116-21
   PubMed Web of Science ®Google Scholar
• Tansey M, Laffel L, Cheng J, et al. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med 2011;28(9):1118-22
   PubMed Web of Science ®Google Scholar
• Beck RW, Lawrence JM, Laffel L, et al. Quality-of-life measures in children and adults with type 1 diabetes: juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010;33(10):2175-7
   PubMed Web of Science ®Google Scholar
• Beck RW, Hirsch IB, Laffel L, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32(8):1378-83
   PubMed Web of Science ®Google Scholar
• Hirose M, Beverly EA, Weinger K. Quality of life and technology: impact on children and families with diabetes. Curr Diab Rep 2012;12(6):711-20
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Group SS. Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med 2013;30(4):464-7
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M, Group SS. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther 2012;14(2):143-51
   PubMed Web of Science ®Google Scholar
• Castle JR, Pitts A, Hanavan K, et al. The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes. Diabetes Care 2012;35(4):706-10
   PubMed Web of Science ®Google Scholar
• Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24(11):1858-62
   PubMed Web of Science ®Google Scholar
• Swan KL, Weinzimer SA, Dziura JD, et al. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008;31(1):44-6
   PubMed Web of Science ®Google Scholar
• Cengiz E, Weinzimer SA, Sherr JL, et al. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. Pediatr Diabetes 2013;14(3):168-73
   PubMed Web of Science ®Google Scholar
• Hompesch M, Muchmore DB, Morrow L, et al. Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. Diabetes Care 2011;34(3):666-8
   PubMed Web of Science ®Google Scholar
• Weinzimer SA, Sherr JL, Cengiz E, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35(10):1994-9
   PubMed Web of Science ®Google Scholar
• Regittnig W, Lindpointner S, Korsatko S, et al. Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients. Diabetes Technol Ther 2013;15(1):50-9
   PubMed Web of Science ®Google Scholar